Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Jefferson Research
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Natus Medical Inc Reaffirms FY 2013 Revenue Guidance; Raises FY 2013 EPS Guidance; Issues Q2 2013 Guidance In Line With Analysts' Estimates


Monday, 6 May 2013 05:30pm EDT 

Natus Medical Inc announced that for fiscal 2013, it expects revenue of $362 million to $367 million and non-GAAP earnings per share of $0.84 to $0.87. For second quarter of 2013, it expects revenue between $86 million to $90 million and non-GAAP earnings per share of $0.17 to $0.20. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $364 million and EPS of $0.84 for fiscal 2013; revenue of $90 million and EPS of $0.19 for second quarter of 2013. 

Company Quote

35.67
-0.6 -1.65%
19 Dec 2014